During the last session, Catheter Precision Inc (AMEX:VTAK)’s traded shares were 1.41 million, with the beta value of the company hitting -0.85. The 52-week high for the VTAK share is $8.40, that puts it down -4321.05 from that peak though still a striking 15.79% gain since the share price plummeted to a 52-week low of $0.16. The company’s market capitalization is $2.08M, and the average trade volume was 533.11K shares over the past three months.

Catheter Precision Inc (AMEX:VTAK) trade information

Catheter Precision Inc (VTAK) registered a 0.96% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.96% in intraday trading to $0.19, hitting a weekly high. The stock’s 5-day price performance is -37.52%, and it has moved by -32.99% in 30 days. Based on these gigs, the overall price performance for the year is -96.41%.

VTAK Dividends

Catheter Precision Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Catheter Precision Inc (AMEX:VTAK)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of Catheter Precision Inc (VTAK) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 43.62 shares. This amounts to just over 0.40 percent of the company’s overall shares, with a $8231.0 market value. The same data shows that the other fund manager holds slightly less at 10.59, or about 0.10% of the stock, which is worth about $1998.0.